IP Library Assignment 023245/0973
Patent Assignment
Reel/Frame 023245/0973

Assignment of Assignor's Interest

Recorded: 2009-09-18 Pages: 8
Assignor
PDL BIOPHARMA, INC.
Executed: 2009-03-09
Assignee
FACET BIOTECH CORPORATION
1500 SEAPORT BLVD., ATTN: LEGAL DEPARTMENT, REDWOOD CITY, CALIFORNIA, 94063
Covered Properties (2)
Alteration of Fcrn Binding Affinities or Serum Half-Lives of Antibodies by Mutagenesis
Patent: 7,217,797 →
Application: 10/687,118 →
Publication: US 2005/0032114
Alteration of Fc-Fusion Protein Serum Half-Lives by Mutagenesis
Patent: 7,217,798 →
Application: 10/966,673 →
Publication: US 2005/0226864
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 14, 2004
From: HINTON, PAUL R; TSURUSHITA, NAOYA; TSO, J. YUN; VASQUEZ, MAXIMILIANO
To: PROTEIN DESIGN LABS, INC.
Reel/Frame 015250/0453 →
Assignment of Assignor's Interest Mar 16, 2005
From: HINTON, PAUL R.; TSURUSHITA, NAOYA
To: PROTEIN DESIGN LABS, INC.
Reel/Frame 015782/0651 →
Change of Name May 22, 2006
From: PROTEIN DESIGN LABS, INC.
To: PDL BIOPHARMA, INC.
Reel/Frame 017655/0436 →
Change of Name Dec 7, 2010
From: FACET BIOTECH CORPORATION
To: ABBOTT BIOTHERAPEUTICS CORP.
Reel/Frame 025445/0807 →
Change of Name Feb 18, 2013
From: ABBOTT BIOTHERAPEUTICS CORP
To: ABBVIE BIOTHERAPEUTICS INC.
Reel/Frame 029825/0070 →